Alto Neuroscience Inc - Novel Transdermal Formulation Delivered Significantly Greater Drug Exposure, Fewer Adverse Events Typically Associated With Pde4 Inhibitors
Alto Neuroscience Inc-新型透皮製劑顯著增加了藥物暴露量,減少了通常與Pde4抑制劑相關的不良事件
Alto Neuroscience Inc - Novel Transdermal Formulation Delivered Significantly Greater Drug Exposure, Fewer Adverse Events Typically Associated With Pde4 Inhibitors
Alto Neuroscience Inc-新型透皮製劑顯著增加了藥物暴露量,減少了通常與Pde4抑制劑相關的不良事件
使用瀏覽器的分享功能,分享給你的好友吧